Quest PharmaTech Inc.
QPT.V
TSX
10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 133.70K | 232.70K | 368.10K | 535.90K | 67.70K |
Total Receivables | 89.70K | 72.40K | 72.80K | 74.70K | 151.20K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 19.90K | 3.40K | 8.50K | 13.90K | 100.00 |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 243.40K | 308.50K | 449.40K | 624.50K | 219.00K |
|
|||||
Total Current Assets | 243.40K | 308.50K | 449.40K | 624.50K | 219.00K |
Net Property, Plant & Equipment | -- | -- | -- | 0.00 | 0.00 |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 4.20K | 4.20K | 4.30K | 4.40K | 4.20K |
Total Assets | 17.37M | 17.43M | 17.05M | 18.29M | 48.48M |
|
|||||
Total Accounts Payable | 42.40K | 11.40K | 2.30K | 208.30K | 90.50K |
Total Accrued Expenses | 16.20K | 40.70K | -- | 32.90K | 28.10K |
Short-term Debt | 717.60K | 723.90K | 727.60K | 747.40K | 720.00K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | 108.80K | -- | -- |
Total Other Current Liabilities | -- | -- | 108.80K | -- | -- |
Total Current Liabilities | 776.20K | 776.00K | 838.70K | 988.70K | 838.60K |
|
|||||
Total Current Liabilities | 776.20K | 776.00K | 838.70K | 988.70K | 838.60K |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | 717.60K | 723.90K | 727.60K | 747.40K | 720.00K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 776.20K | 776.00K | 838.70K | 988.70K | 838.60K |
|
|||||
Common Stock & APIC | 30.45M | 30.66M | 30.81M | 31.65M | 30.45M |
Retained Earnings | -13.77M | -13.92M | -14.51M | -14.26M | 17.27M |
Treasury Stock & Other | -84.90K | -83.10K | -87.50K | -82.70K | -82.40K |
Total Common Equity | 16.59M | 16.66M | 16.21M | 17.31M | 47.64M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 16.59M | 16.66M | 16.21M | 17.31M | 47.64M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 16.59M | 16.66M | 16.21M | 17.31M | 47.64M |
|